ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Biochemical and Biophysical Research Communications
Volume 290, Issue 1, 11 January 2002, Pages 11-15
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Purchase PDF (277 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1006/bbrc.2001.6096    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2002 Elsevier Science (USA). All rights reserved.

Regular Article

c-myc Suppression in Burkitt's Lymphoma Cells

Tomas Simonssona, 1 and Marie Henrikssonb

a Department of Molecular Biotechnology, Lundberg Laboratory, Chalmers University of Technology, P.O. Box 462, SE 405 30, Göteborg, Sweden b Microbiology and Tumor Biology Center, Karolinska Institute, P.O. Box 280, SE 171 77, Stockholm, Sweden

Received 6 October 2001. 
Available online 26 February 2002.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

The purpose of the study was to elucidate how DNA tetraplex (also referred to as G-quadruplex)-forming oligonucleotides mediate suppression of the human c-myc gene at the level of transcription initiation. A 22-base-long oligonucleotide, which is rich in guanines and folds into an intrastrand DNA tetraplex under physiological conditions, was administered to a Burkitt's lymphoma cell line overexpressing a (8:14) translocated c-myc allele. Administration of the oligonucleotide at nanomolar concentrations to the surrounding medium resulted in efficient cellular uptake, and was accompanied by a substantial concentration- and conformation-dependent decrease in growth rate. We discuss how c-myc transcription is initiated at the molecular level and speculate that the oligonucleotide exerts a dual effect on c-myc expression in vivo.

Author Keywords: anticancer drug; chromatin; G-quartet; gene therapy; promoter; telomere


 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.